We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

North East Based Biotechnology Firm, Glythera Receives £700k Funding Boost

Product News   Jul 09, 2013

 
North East Based Biotechnology Firm, Glythera Receives £700k Funding Boost
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

Univercells Technologies introduces the NevoLine™ Upstream Platform

Product News

This upstream manufacturing platform is suitable for multiple viral applications to support the booming gene therapy market and offer a cost-effective tool for rapid response to emerging infectious diseases.

READ MORE

Arctoris and Syntekabio Form Drug Discovery Research Partnership

Product News

The first project under the agreement sees the two companies work together to assess small molecule therapeutics for COVID-19.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE